Related Experiment Video

Updated: May 12, 2026

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

Genetic and epigenetic studies for determining molecular targets of natural product anticancer agents

Yujiong Wang1, Yong Li, Xiaoming Liu

  • 1Key Laboratory of the Ministry of Education for Conservation and Utilization of Special Biological Resources in Western China, Ningxia 750021, China.

Current Cancer Drug Targets
|April 20, 2013
PubMed

Insights

Natural products like EGCG and curcumin show anticancer potential by targeting genetic and epigenetic changes. These compounds can modify cancer cell behavior and signaling pathways, offering promise for cancer prevention and treatment.

Area of Science:

  • Oncology
  • Pharmacology
  • Biochemistry

Background:

  • Cancer arises from genetic and epigenetic alterations.
  • Natural products are increasingly recognized for their therapeutic potential.
  • Epigenetic modifications play a crucial role in cancer development and progression.

Purpose of the Study:

  • To review the anticancer properties of natural products.
  • To discuss the mechanisms by which natural products target genetic and epigenetic machinery.
  • To explore the role of natural products in cancer chemoprevention and treatment.

Main Methods:

  • Literature review of studies on natural products and cancer.
  • Analysis of mechanisms involving DNA methylation, histone modification, and microRNA regulation.
  • Examination of effects on cancer stem cells and signaling pathways.

Main Results:

  • Common natural products (EGCG, curcumin, genistein, SFN, resveratrol) exhibit anticancer effects.
  • These compounds modulate epigenetic processes, including DNA methylation and histone modification.
  • Natural products can target cancer stem cells and interfere with cancer signaling pathways.

Conclusions:

  • Natural products hold significant promise for cancer prevention and treatment.
  • Targeting epigenetic modifications with natural compounds is a viable therapeutic strategy.
  • Further research into natural products can lead to novel anticancer drug development.

More Related Videos

Assessing Specificity of Anticancer Drugs In Vitro09:39

Assessing Specificity of Anticancer Drugs In Vitro

Published on: March 23, 2016

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Pharmacogenetics and Pharmacogenomics: Overview01:29

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...